DOCUSATE SODIUM WITH SENNOSIDES- docusate sodium 50mg and sennosides 8.6mg tablet, film coated 
PD-Rx Pharmaceuticals, Inc.

----------

Drug Facts

Active Ingredients (in each tablet)

Sennosides from Senna Concentrate 8.6mg

Docusate Sodium 50mg

Purpose

Laxative

Stool Softner

Uses

Warnings

Do not use

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after the use of a laxative. These may indicate a serious condition.

If pregnant or breast feeding,

ask a healthcare professional before use. 

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.(800) 222-1222.

Directions

age

starting dosage

maximum dosage

Adults and children 12 years and over

2 tablets once daily

4 tablets twice daily

Children 6 to under 12 years

1 tablet once daily

2 tablets  twice daily

Children 2 to under 6 years 

1/2 tablet  once daily

1 tablet twice daily

Children under 2 years

ask a doctor

ask a  doctor

Other information

Inactive ingredients

crosscarmellose Sodium, D&C Yellow# 10, dicalcium phosphate, FD&C Yellow #6, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol, polyethylene glycol, sodium benzoate, talc, titanium dioxide

Questions or comments?

(866) 562-2756 Mon-Fri 8 AM to 4 PM EST

16 HOW SUPPLIED/STORAGE AND HANDLING

Docusate Sodium with Sennosides is a orange, round tablet; Debossed with PH32.

Bottles of 100 NDC 43063-958-01

Bottles of 1000 NDC 43063-958-95

Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F).

NDC 43063-958-01

Manufactured in the USA

*Compare to the active ingredients in Senokot-S ®

Docusate Sodium 50mg &

Sennosides 8.6mg

Natural Vegetable Laxative

Ingredient Plus Stool Softner

100 TABLETS

IMAGE

DOCUSATE SODIUM WITH SENNOSIDES 
docusate sodium 50mg and sennosides 8.6mg tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43063-958(NDC:16103-378)
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
Colororange (ORANGE COLOR) Scoreno score
ShapeROUND (ROUND TABLET) Size10mm
FlavorImprint Code PH32
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:43063-958-01100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product03/21/2019
2NDC:43063-958-951000 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product12/17/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00711/05/2018
Labeler - PD-Rx Pharmaceuticals, Inc. (156893695)
Registrant - PD-Rx Pharmaceuticals, Inc. (156893695)
Establishment
NameAddressID/FEIBusiness Operations
PD-Rx Pharmaceuticals, Inc.156893695repack(43063-958)

Revised: 10/2023
Document Id: 06d13207-c1fe-8cee-e063-6394a90a21a0
Set id: 468f37ce-c696-4606-b387-b5a065b6b184
Version: 7
Effective Time: 20231003
 
PD-Rx Pharmaceuticals, Inc.